ArticleFrontiers in nutrition2025
Inverse associations between dietary flavonoid and subclass intakes and frailty in U.S. adults.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Relationship between berry intake and frailty in the elderly and the mediating role of six blood markers: based on Chinese and American studies.Frontiers in nutrition · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Dietary flavonoids, known for their antioxidant and anti-inflammatory properties, may play a role in frailty prevention, but comprehensive population-based studies are lacking. This study aimed to examine the associations between dietary flavonoid intakes and the prevalence of frailty in a nationally representative sample of U.S. adults, and to identify the predominant flavonoid subclasses contributing to these associations. Methods: Cross-sectional data from 12,152 adults aged ≥20 years participating in the National Health and Nutrition Examination Survey (NHANES) 2007-2010 and 2017-2018 were analyzed. Dietary flavonoid intake was assessed using two 24-h dietary recalls. Frailty was defined using a 49-item frailty index. Weighted multivariate logistic regression models and restricted cubic spline analyses were employed to investigate the relationships between flavonoid intakes and frailty prevalence. Weighted quantile sum (WQS) regression and quantile g-computation (qgcomp) models were used to assess the mixed effects of flavonoid subclasses. Results: Higher intakes of total flavonoids (OR:0.79, 95% CI:0.65-0.95), anthocyanidins (OR:0.71, 95% CI:0.58-0.88), flavanones (OR:0.74, 95% CI:0.59-0.92), flavones (OR:0.76, 95% CI:0.59-0.97), and flavonols (OR:0.67, 95% CI:0.56-0.81) were significantly associated with lower prevalence of frailty after adjusting for confounders. Non-linear inverse associations were observed for total flavonoids and flavonols. The WQS model revealed that the mixture of flavonoid subclasses was inversely associated with frailty odds (OR: 0.58, 95% CI: 0.48-0.71, Conclusion: This comprehensive analysis provides evidence that higher dietary flavonoid intakes, particularly flavones, flavonols, and anthocyanidins, are associated with lower prevalence of frailty in U.S. adults. These findings suggest that flavonoid-rich diets may be a promising strategy for frailty prevention, warranting further investigation through prospective cohort studies and randomized controlled trials.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.